Oral Anticoagulant Usage among High-Risk Atrial Fibrillation Patients and Their Benefits

Activity: Talk or presentation types › Oral presentation

Description

Oral anticoagulants (OAC) can be divided in two groups: K vitamin antagonists, most commonly warfarin used in Latvia and direct oral anticoagulants, such as rivaroxaban, edoxaban, apixaban and dabigatran. This diverse group of medication should be prescribed for high risk (CHA2DS2-VASc equal or more than 2 points for male patients and 3 or more points for female) atrial fibrillation patients who does not have moderate to severe mitral valve stenosis or prosthetic mechanical valve replacements in medical history. OAC by acting on different steps of coagulation cascade prevents patient from thrombus development in left atrial appendage and therefor further risk for thromboembolism in cerebral arteries causing cerebral infarction. The cerebral infarction prevention by using oral anticoagulants lets patients with high-risk atrial fibrillation live a healthier and longer life, preserving both physical health as well as health-related quality of life in the long term. Both oral anticoagulant types have their pros and cons and a deeper understanding of their mechanism of work should be understood to choose the most appropriate treatment for the patient. This lecture focuses on reveling how different oral anticoagulants can affect our physical and mental health in long run through different mechanisms and gives a deeper understanding of this drug class.. .. .. .
Period29 Mar 2023
Event titleRSU International Research Conference 2023: Knowledge for Use in Practice
Event typeConference
OrganiserRīga Stradiņš University
LocationRiga, LatviaShow on map
Degree of RecognitionInternational

Related content